Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.42 USD | +1.62% | +4.54% | +18.32% |
04-11 | Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes | MT |
02-26 | Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating | MT |
Sales 2024 * | 584M 798M | Sales 2025 * | 596M 815M | Capitalization | 1.19B 1.63B |
---|---|---|---|---|---|
Net income 2024 * | 116M 159M | Net income 2025 * | 144M 197M | EV / Sales 2024 * | 2.33 x |
Net Debt 2024 * | 167M 228M | Net cash position 2025 * | 42.16M 57.62M | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
12.3
x | P/E ratio 2025 * |
9.92
x | Employees | 197 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.62% |
Latest transcript on Collegium Pharmaceutical, Inc.
1 day | +1.62% | ||
1 week | +4.54% | ||
Current month | -6.18% | ||
1 month | -8.79% | ||
3 months | +9.76% | ||
6 months | +66.30% | ||
Current year | +18.32% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 01-12-31 | |
Joseph Ciaffoni
CEO | Chief Executive Officer | 53 | 17-05-30 |
Colleen Tupper
DFI | Director of Finance/CFO | 48 | 21-05-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 14-12-31 |
Gino Santini
BRD | Director/Board Member | 66 | 12-07-23 |
John Freund
BRD | Director/Board Member | 70 | 14-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 29 M€ | -4.33% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 36.42 | +1.62% | 252,821 |
24-04-25 | 35.84 | +1.01% | 338,007 |
24-04-24 | 35.48 | -1.28% | 302,816 |
24-04-23 | 35.94 | +3.45% | 618,659 |
24-04-22 | 34.74 | -0.29% | 414,728 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.32% | 1.19B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- COLL Stock